➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Medtronic
McKesson
Dow
Merck

Last Updated: June 17, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for SM04690


Email this page to a colleague

« Back to Dashboard

What is the drug development status for SM04690?

SM04690 is an investigational drug.

There have been 10 clinical trials for SM04690. The most recent clinical trial was a Phase 1 trial, which was initiated on May 1st 2019.

The most common disease conditions in clinical trials are Osteoarthritis, Osteoarthritis, Knee, and Spinal Diseases. The leading clinical trial sponsors are Samumed LLC and [disabled in preview].

There are ten US patents protecting this investigational drug and eighty international patents.

Recent Clinical Trials for SM04690
TitleSponsorPhase
Drug-Drug Interaction Study of Lorecivivint and Triamcinolone Acetonide in Healthy VolunteersSamumed LLCPhase 1
Extension Study Evaluating the Safety and Efficacy of a Second Year of Use of Lorecivivint in Subjects With Osteoarthritis of the KneeSamumed LLCPhase 3
A Study Utilizing Patient-Reported Outcomes to Evaluate the Safety and Efficacy of Lorecivivint (SM04690) for the Treatment of Moderately to Severely Symptomatic Knee OsteaoarthritisSamumed LLCPhase 3

See all SM04690 clinical trials

Clinical Trial Summary for SM04690

Top disease conditions for SM04690
Top clinical trial sponsors for SM04690

See all SM04690 clinical trials

US Patents for SM04690

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
SM04690   Get Started Free Process for preparing N-(5-(3-(7-(3-fluorophenyl)-3H-imidazo [4,5-C]pyridin-2-yl)-1H-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide Samumed, LLC (San Diego, CA)   Get Started Free
SM04690   Get Started Free Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof Samumed, LLC (San Diego, CA)   Get Started Free
SM04690   Get Started Free Treatment of osteoarthritis Samumed, LLC (San Diego, CA)   Get Started Free
SM04690   Get Started Free Process for preparing N-(5-(3-(7-(3-fluorophenyl)-3H-imidazo[4,5-C]pyridin-2-yl)-1H-indazol-5-y- l)pyridin-3-yl)-3-methylbutanamide Samumed, LLC (San Diego, CA)   Get Started Free
SM04690   Get Started Free Single-dose, ready-to-use injectable formulations Samumed, LLC (San Diego, CA)   Get Started Free
SM04690   Get Started Free Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof Samumed, LLC (San Diego, CA)   Get Started Free
SM04690   Get Started Free Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof Samumed, LLC (San Diego, CA)   Get Started Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for SM04690

Drugname Country Document Number Estimated Expiration Related US Patent
SM04690 Australia AU2017274350 2036-06-01   Get Started Free
SM04690 Brazil BR112018074725 2036-06-01   Get Started Free
SM04690 Canada CA3026076 2036-06-01   Get Started Free
SM04690 Chile CL2018003423 2036-06-01   Get Started Free
SM04690 China CN109476660 2036-06-01   Get Started Free
SM04690 European Patent Office EP3464285 2036-06-01   Get Started Free
SM04690 Israel IL263362 2036-06-01   Get Started Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
Boehringer Ingelheim
Dow
AstraZeneca
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.